Nexalin Technology, Inc. (NXL)

1.4350 -0.1750 (-10.87%) At close: 04:00PM EDT

Nexalin Technology, Inc.

1776 Yorktown
Suite 550
Houston, TX 77056
United States
(832) 260-0222
https://www.nexalin.com

Sector(s): Healthcare
Industry: Medical Devices
Full Time Employees: 6

Description

Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health in the United States and China. The company designs and develops Generation 2 and Generation 3, that is in clinical trials for the treatment of substance abuse issues related to opiate, cocaine, alcohol abuse, alzheimer's disease, and dementia. It also licenses and sells Nexalin Device, a non-invasive and undetectable to the human body that can provide relief to its afflicted with mental health issues. The company is based in Houston, Texas.

Corporate Governance

Nexalin Technology, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.